Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
Ladetto, M, Brüggemann, M, Monitillo, L, Ferrero, S, Pepin, F, Drandi, D, Barbero, D, Palumbo, A, Passera, R, Boccadoro, M, Ritgen, M, Gökbuget, N, Zheng, J, Carlton, V, Trautmann, H, Faham, M, Pott, C
Published in Leukemia (01.06.2014)
Published in Leukemia (01.06.2014)
Get full text
Journal Article
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Hallek, M, Prof, Fischer, K, MD, Fingerle-Rowson, G, MD, Fink, AM, MD, Busch, R, Mayer, J, Prof, Hensel, M, Prof, Hopfinger, G, MD, Hess, G, MD, von Grünhagen, U, MD, Bergmann, M, MD, Catalano, J, MD, Zinzani, PL, Prof, Caligaris-Cappio, F, Prof, Seymour, JF, Prof, Berrebi, A, Prof, Jäger, U, Prof, Cazin, B, MD, Trneny, M, MD, Westermann, A, Wendtner, CM, Prof, Eichhorst, BF, MD, Staib, P, MD, Bühler, A, MD, Winkler, D, MD, Zenz, T, MD, Böttcher, S, MD, Ritgen, M, MD, Mendila, M, MD, Kneba, M, Prof, Döhner, H, Prof, Stilgenbauer, S, Prof
Published in The Lancet (British edition) (02.10.2010)
Published in The Lancet (British edition) (02.10.2010)
Get full text
Journal Article
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
Kalina, T, Flores-Montero, J, van der Velden, V H J, Martin-Ayuso, M, Böttcher, S, Ritgen, M, Almeida, J, Lhermitte, L, Asnafi, V, Mendonça, A, de Tute, R, Cullen, M, Sedek, L, Vidriales, M B, Pérez, J J, te Marvelde, J G, Mejstrikova, E, Hrusak, O, Szczepański, T, van Dongen, J J M, Orfao, A
Published in Leukemia (01.09.2012)
Published in Leukemia (01.09.2012)
Get full text
Journal Article
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
Al-Sawaf, O, Robrecht, S, Bahlo, J, Fink, A M, Cramer, P, V Tresckow, J, Lange, E, Kiehl, M, Dreyling, M, Ritgen, M, Dürig, J, Tausch, E, Schneider, C, Stilgenbauer, S, Wendtner, C M, Fischer, K, Goede, 5th, Hallek, M, Eichhorst, B
Published in Leukemia (01.01.2021)
Published in Leukemia (01.01.2021)
Get full text
Journal Article
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL
Rawstron, A C, Böttcher, S, Letestu, R, Villamor, N, Fazi, C, Kartsios, H, de Tute, R M, Shingles, J, Ritgen, M, Moreno, C, Lin, K, Pettitt, A R, Kneba, M, Montserrat, E, Cymbalista, F, Hallek, M, Hillmen, P, Ghia, P
Published in Leukemia (01.01.2013)
Published in Leukemia (01.01.2013)
Get full text
Journal Article
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL
Maurer, C, Langerbeins, P, Bahlo, J, Cramer, P, Fink, A M, Pflug, N, Engelke, A, von Tresckow, J, Kovacs, G, Stilgenbauer, S, Wendtner, C-M, Müller, L, Ritgen, M, Seiler, T, Fischer, K, Hallek, M, Eichhorst, B
Published in Leukemia (01.10.2016)
Published in Leukemia (01.10.2016)
Get full text
Journal Article
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis
BÖTTCHER, S, STILGENBAUER, S, KNEBA, M, RITGEN, M, BUSCH, R, BRÜGGEMANN, M, RAFF, T, POTT, C, FISCHER, K, FINGERLE-ROWSON, G, DÖHNER, H, HALLEK, M
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia
RAWSTRON, A. C, VILLAMOR, N, EVAN, P. A. S, NATKUNAM, Y, COUTRE, S. E, AVERY, E. D, RASSENTI, L. Z, KIPPS, T. J, CALIGARIS-CAPPIO, F, KNEBA, M, BYRD, J. C, HALLEK, M. J, RITGEN, M, MONTSERRAT, E, HILLMEN, P, BÖTTCHER, S, GHIA, P, ZEHNDER, J. L, LOZANSKI, G, COLOMER, D, MORENO, C, GEUNA, M
Published in Leukemia (01.05.2007)
Published in Leukemia (01.05.2007)
Get full text
Journal Article
Skin involvement by chronic lymphocytic leukaemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression
Thiesen, I., Wehkamp, U., Brüggemann, M., Ritgen, M., Murga Penas, E.M., Klapper, W., Oschlies, I.
Published in British journal of dermatology (1951) (01.01.2019)
Published in British journal of dermatology (1951) (01.01.2019)
Get full text
Journal Article
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia
Fürstenau, M, Bahlo, J, Fink, A M, Lange, E, Dreger, P, Dreyling, M, Hess, G, Ritgen, M, Kneba, M, Döhner, H, Stilgenbauer, S, Wendtner, C M, Goede, V, Fischer, K, Böttcher, S, Hallek, M, Eichhorst, B
Published in Leukemia (01.03.2020)
Published in Leukemia (01.03.2020)
Get full text
Journal Article
Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in
Goede, V, Fischer, K, Busch, R, Jaeger, U, Dilhuydy, M-S, Wickham, N, De Guibert, S, Ritgen, M, Langerak, A W, Bieska, G, Engelke, A, Humphrey, K, Wenger, M, Hallek, M
Published in Leukemia (01.05.2013)
Published in Leukemia (01.05.2013)
Get full text
Journal Article
A PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX COMPARED TO OBINUTUZUMAB AND VENETOCLAX IN PATIENTS WITH HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA
Kutsch, N., Fink, A. M., Robrecht, S., Tausch, E., Schneider, C., Dierks, C., Wendtner, C., Meyer, R., Gaska, T., Chakupurakal, G., Jentsch‐Ullrich, K., Steiniger, H., Schwaner, I., Neumann, C., Fischer, K., Kreuzer, K., Ritgen, M., Stilgenbauer, S., Hallek, M., Eichhorst, B.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY
Al‐Sawaf, O., Robrecht, S., Zhang, C., Olivieri, S., Chang, Y. M., Fink, A. M., Tausch, E., Schneider, C., Ritgen, M., Kreuzer, K., Sivcheva, L., Niemann, C., Schwarer, A., Loscertales, J., Weinkove, R., Strumberg, D., Kilfoyle, A., Runkel, E. D., Eichhorst, B., Stilgenbauer, S., Jiang, Y., Hallek, M., Fischer, K.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse
Hahn, M, Böttcher, S, Dietrich, S, Hegenbart, U, Rieger, M, Stadtherr, P, Bondong, A, Schulz, R, Ritgen, M, Schmitt, T, Tran, T H, Görner, M, Herth, I, Luft, T, Schönland, S, Witzens-Harig, M, Zenz, T, Kneba, M, Ho, A D, Dreger, P
Published in Bone marrow transplantation (Basingstoke) (01.10.2015)
Published in Bone marrow transplantation (Basingstoke) (01.10.2015)
Get full text
Journal Article
VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY
Al‐Sawaf, O., Zhang, C., Robrecht, S., Tandon, M., Panchal, A., Fink, A.‐M., Tausch, E., Ritgen, M., Kreuzer, K.‐A., Kim, S., Wendtner, C., Eichhorst, B., Stilgenbauer, S., Jiang, Y., Hallek, M., Fischer, K.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATION
Al‐Sawaf, O., Robrecht, S., Stumpf, J., Fink, A.‐M., Ritgen, M., Johansson, P., Tausch, E., Hoechstetter, M., Staber, P., Jäger, U., Niemann, C. U., Pallasch, C., Kreuzer, K.‐A., Stilgenbauer, S., Fischer, K., Wendtner, C., Hallek, M., Eichhorst, B.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission - experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
WENDTNER, C-M, RITGEN, M, STILGENBAUER, S, DÖHNER, H, KNEBA, M, EMMERICH, B, HALLEK, M, SCHWEIGHOFER, C. D, FINGERLE-ROWSON, G, CAMPE, H, JÄGER, G, EICHHORST, B, BUSCH, R, DIEM, H, ENGERT, A
Published in Leukemia (01.06.2004)
Published in Leukemia (01.06.2004)
Get full text
Journal Article
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial
RITGEN, M, BOTTCHER, S, DÖHNER, H, DREGER, P, STILGENBAUER, S, BUNJES, D, SCHUBERT, J, COHEN, S, HUMPE, A, HALLEK, M, KNEBA, M, SCHMITZ, N
Published in Leukemia (01.07.2008)
Published in Leukemia (01.07.2008)
Get full text
Journal Article
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
Fink, A M, Böttcher, S, Ritgen, M, Fischer, K, Pflug, N, Eichhorst, B, Wendtner, C-M, Winkler, D, Bühler, A, Zenz, T, Staib, P, Mayer, J, Hensel, M, Hopfinger, G, Wenger, M, Fingerle-Rowson, G, Döhner, H, Kneba, M, Stilgenbauer, S, Busch, R, Hallek, M
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation
BÖTTCHER, S, RITGEN, M, POTT, C, BRÜGGEMANN, M, RAFF, T, STILGENBAUER, S, DÖHNER, H, DREGER, P, KNEBA, M
Published in Leukemia (01.10.2004)
Published in Leukemia (01.10.2004)
Get full text
Journal Article